Distillate Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$4.74M |
| 2 |
Automatic Data Processing
ADP
|
+$3.73M |
| 3 |
Norfolk Southern
NSC
|
+$3.38M |
| 4 |
Amphenol
APH
|
+$3.32M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$3.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$7.95M |
| 2 |
Apple
AAPL
|
+$7.53M |
| 3 |
Blackrock
BLK
|
+$4.32M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$4.28M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.47% |
| 2 | Healthcare | 21.25% |
| 3 | Industrials | 19.44% |
| 4 | Consumer Discretionary | 12.31% |
| 5 | Consumer Staples | 8.4% |
Similar funds
Distillate Capital Partners's Q3 2021 Portfolio in Review
As of Q3 2021, Distillate Capital Partners held 140 positions worth $376M, up 4.5% from $360M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Distillate Capital Partners deployed $24.9M of net new capital in Q3 2021, opening 26 new positions and adding to 73 existing holdings. Its largest new stake was Elevance Health: 12,461 shares worth $4.64M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Bath & Body Works, an estimated $715K trimmed.
- Distillate Capital Partners's largest Q3 2021 buy was Elevance Health: 12,461 shares worth $4.64M.
- Distillate Capital Partners added most to Johnson & Johnson in Q3 2021, an estimated $2.55M increase.
- Distillate Capital Partners's biggest Q3 2021 reduction was Bath & Body Works, cutting an estimated $715K.
- Distillate Capital Partners fully exited Alphabet (Google) Class A in Q3 2021, selling an estimated $7.95M.
- Distillate Capital Partners's ten largest holdings make up 21% of its $376M portfolio in Q3 2021.
- Distillate Capital Partners opened 26 new positions and closed 30 in Q3 2021.
- Distillate Capital Partners's portfolio value rose 4.5% quarter-over-quarter to $376M.
Based on Distillate Capital Partners's 13F filing for Q3 2021, filed 5 Nov 2021.